Risuntek Inc. (SHE:002981)
China · Delayed Price · Currency is CNY 30.15
+0.15 (0.50%)
Feb 13, 2026, 3:04 PM CST
Risuntek Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,967 | 1,721 | 1,407 | 1,376 | 1,304 | 902.51 |
Other Revenue | 13.12 | 13.12 | 23.1 | 9.78 | 5.77 | 2.2 |
| 1,980 | 1,734 | 1,430 | 1,385 | 1,310 | 904.72 | |
Revenue Growth (YoY) | 22.85% | 21.24% | 3.25% | 5.79% | 44.76% | 9.31% |
Cost of Revenue | 1,562 | 1,372 | 1,109 | 1,168 | 1,237 | 760.49 |
Gross Profit | 418.3 | 362.73 | 321.7 | 217.37 | 72.77 | 144.23 |
Selling, General & Admin | 157.37 | 152.66 | 133.61 | 101.47 | 70.43 | 46.69 |
Research & Development | 103.16 | 82.25 | 62.89 | 52.61 | 56.93 | 38.67 |
Other Operating Expenses | 12.22 | 12.57 | 7.46 | 6.48 | 3.99 | 4 |
Operating Expenses | 278.44 | 256.88 | 208.32 | 161.29 | 129.15 | 87.33 |
Operating Income | 139.86 | 105.85 | 113.38 | 56.08 | -56.37 | 56.9 |
Interest Expense | -2.93 | -2.18 | -8.92 | -11.16 | -4.53 | -1.5 |
Interest & Investment Income | 5.41 | 5.03 | 7.94 | 2.49 | 5.55 | 4.77 |
Currency Exchange Gain (Loss) | 16.08 | 16.08 | 4.3 | 29.23 | -3.34 | -14.76 |
Other Non Operating Income (Expenses) | 2.58 | 0.16 | 0.4 | -0.67 | -0.33 | -0.06 |
EBT Excluding Unusual Items | 160.99 | 124.96 | 117.1 | 75.98 | -59.02 | 45.35 |
Impairment of Goodwill | - | - | -18.42 | -8.55 | - | - |
Gain (Loss) on Sale of Investments | - | 2.2 | 29.86 | -2.33 | 1.28 | - |
Gain (Loss) on Sale of Assets | 2.22 | 0.11 | -0.01 | - | 0.02 | - |
Asset Writedown | -14.88 | -4.36 | 0 | -1.42 | - | -0.09 |
Other Unusual Items | 1.53 | 3.26 | 3.03 | 3.11 | 2.19 | 4.18 |
Pretax Income | 149.87 | 126.16 | 131.56 | 66.79 | -55.52 | 49.45 |
Income Tax Expense | 13.75 | 10.85 | 12.56 | 4.96 | -13.93 | 3.99 |
Earnings From Continuing Operations | 136.12 | 115.31 | 118.99 | 61.84 | -41.6 | 45.46 |
Minority Interest in Earnings | 0.03 | -2.41 | -2.22 | -3.73 | - | - |
Net Income | 136.15 | 112.91 | 116.78 | 58.11 | -41.6 | 45.46 |
Net Income to Common | 136.15 | 112.91 | 116.78 | 58.11 | -41.6 | 45.46 |
Net Income Growth | 17.50% | -3.31% | 100.97% | - | - | -45.32% |
Shares Outstanding (Basic) | 135 | 134 | 134 | 133 | 135 | 122 |
Shares Outstanding (Diluted) | 135 | 134 | 134 | 133 | 135 | 122 |
Shares Change (YoY) | 0.39% | 0.14% | 0.65% | -1.54% | 10.66% | 20.93% |
EPS (Basic) | 1.01 | 0.84 | 0.87 | 0.44 | -0.31 | 0.37 |
EPS (Diluted) | 1.01 | 0.84 | 0.87 | 0.44 | -0.31 | 0.37 |
EPS Growth | 17.04% | -3.45% | 99.68% | - | - | -54.78% |
Free Cash Flow | 60.65 | 23.87 | 95.99 | -2.02 | -83.8 | -153.66 |
Free Cash Flow Per Share | 0.45 | 0.18 | 0.71 | -0.01 | -0.62 | -1.25 |
Dividend Per Share | 0.260 | 0.260 | 0.264 | 0.107 | - | 0.036 |
Dividend Growth | -1.63% | -1.63% | 146.78% | - | - | -50.00% |
Gross Margin | 21.12% | 20.92% | 22.49% | 15.69% | 5.56% | 15.94% |
Operating Margin | 7.06% | 6.10% | 7.93% | 4.05% | -4.30% | 6.29% |
Profit Margin | 6.88% | 6.51% | 8.16% | 4.19% | -3.18% | 5.03% |
Free Cash Flow Margin | 3.06% | 1.38% | 6.71% | -0.15% | -6.40% | -16.98% |
EBITDA | 195.17 | 164.85 | 177.29 | 109.39 | -23.03 | 75.57 |
EBITDA Margin | 9.86% | 9.51% | 12.39% | 7.90% | -1.76% | 8.35% |
D&A For EBITDA | 55.32 | 59 | 63.91 | 53.31 | 33.34 | 18.67 |
EBIT | 139.86 | 105.85 | 113.38 | 56.08 | -56.37 | 56.9 |
EBIT Margin | 7.06% | 6.10% | 7.93% | 4.05% | -4.30% | 6.29% |
Effective Tax Rate | 9.17% | 8.60% | 9.55% | 7.42% | - | 8.06% |
Revenue as Reported | 1,980 | 1,734 | 1,430 | 1,385 | 1,310 | 904.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.